Everolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex
David Neal Franz Department of Pediatrics, Tuberous Sclerosis Clinic, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA Abstract: Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder caused by inactivating mutations in either the TSC1 or TSC2 genes. It...
Saved in:
Main Author: | Franz DN |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/41bc3f129b4f4366a7ce06a3cc1cc93a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
by: Cong Luo, et al.
Published: (2021) -
Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
by: Capal JK, et al.
Published: (2016) -
Aggressive retinal astrocytoma associated with tuberous sclerosis
by: Tomida M, et al.
Published: (2012) -
The genomic landscape of tuberous sclerosis complex
by: Katie R. Martin, et al.
Published: (2017) -
Dermoscopy of Facial Angiofibromas in Four Patients of Skin of Color with Tuberous Sclerosis Complex: A Case-Series
by: Rashmi Jindal, et al.
Published: (2021)